These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25524814)

  • 1. Reply: To PMID 25524879.
    Kerasnoudis A; Yoon MS
    Muscle Nerve; 2015 Mar; 51(3):459-60. PubMed ID: 25524814
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of ultrasonography versus clinical examination in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy: The importance of timing.
    Rajabally YA; Hiew FL
    Muscle Nerve; 2015 Mar; 51(3):459. PubMed ID: 25524879
    [No Abstract]   [Full Text] [Related]  

  • 3. Bochum ultrasound score versus clinical and electrophysiological parameters in distinguishing acute-onset chronic from acute inflammatory demyelinating polyneuropathy.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    Muscle Nerve; 2015 Jun; 51(6):846-52. PubMed ID: 25297575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is new in 2015 in dysimmune neuropathies?
    Kuntzer T
    Rev Neurol (Paris); 2016 Dec; 172(12):779-784. PubMed ID: 27866728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study.
    Zaidman CM; Al-Lozi M; Pestronk A
    Muscle Nerve; 2009 Dec; 40(6):960-6. PubMed ID: 19697380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions.
    Blum S; McCombe PA
    J Peripher Nerv Syst; 2014 Jun; 19(2):88-103. PubMed ID: 25039604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
    Tanaka R; Maruyama H; Tomidokoro Y; Yanagiha K; Hirabayashi T; Ishii A; Okune M; Inoue S; Sekine I; Tamaoka A; Fujimoto M
    Jpn J Clin Oncol; 2016 Sep; 46(9):875-8. PubMed ID: 27380808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation.
    Pritchard J; Mukherjee R; Hughes RA
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):348-9. PubMed ID: 12185184
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of POEMS mimicking a "Guillain-Barré like" syndrome.
    Abbas A; Cook M; Hiew FL; Lewthwaite A; Shirley C; Rajabally YA
    J Neurol Sci; 2016 Oct; 369():268-270. PubMed ID: 27653904
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus associated relapsing polyneuropathy: recurrent Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy?
    Zhang H; Wu J
    Muscle Nerve; 2011 Oct; 44(4):609-10; author reply 610. PubMed ID: 21922475
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: biomarkers of 'acute-onset' chronic inflammatory demyelinating polyneuropathy.
    Park SB; Sung JY; Tani J; Kiernan MC; Lin CS
    Brain; 2015 Mar; 138(Pt 3):e336. PubMed ID: 25183715
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barre or CIDP? That is the question.
    Smith BE
    Neurology; 2010 May; 74(21):1664-5. PubMed ID: 20445150
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori may play an important role in both axonal type Guillain-Barré syndrome and acute inflammatory demyelinating polyradiculoneuropathy.
    Kountouras J; Zavos C; Deretzi G; Gavalas E; Polyzos S; Vardaka E; Kountouras C; Giartza-Taxidou E; Koutlas E; Tsiptsios I
    Clin Neurol Neurosurg; 2011 Jul; 113(6):520. PubMed ID: 21316838
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on acute-onset chronic inflammatory demyelinating polyneuropathy versus fluctuating Guillain-Barré syndrome.
    Galassi G
    Muscle Nerve; 2011 Oct; 44(4):610-2; author reply 612. PubMed ID: 21922476
    [No Abstract]   [Full Text] [Related]  

  • 16. Deterioration after Guillain-Barré syndrome: recurrence, treatment-related fluctuation or CIDP?
    Hadden RD
    J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):3. PubMed ID: 19091702
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients.
    van der Zwan M; Hesselink DA; Brusse E; van Doorn PA; van den Hoogen MWF; de Weerd AE; Jacobs BC
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32299841
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology.
    Franssen H; Straver DC
    Muscle Nerve; 2014 Jan; 49(1):4-20. PubMed ID: 24037667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis.
    Blum S; Csurhes P; McCombe P
    J Neuroimmunol; 2015 Aug; 285():53-6. PubMed ID: 26198918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual patients who experienced both Guillain-Barré syndrome and CIDP.
    Kuitwaard K; van der Pol WL; Ruts L; van Doorn PA
    J Peripher Nerv Syst; 2009 Mar; 14(1):66-8. PubMed ID: 19335542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.